 |
인쇄하기
취소
|
R&D-oriented pharmaceutical firms to benefit from exemption of drug price cut
Published: 2010-10-08 06:58:00
Updated: 2010-10-08 06:58:00
The drug price cut will be significantly exempted for drugmakers who intend to spend more money on the research and development (R&D) of new drugs, according to the Ministry of Health and Welfare.
Pharmaceutical manufacturers making an investment of 50 billion won in their R&D projects will have the price cut of individual medicines exempted by 72 percent, from the current scope of 60 percen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.